oral formulation

Related by string. oral formulations * ORAL . orals . Oral : hear oral arguments . TULSA Okla. Oral Roberts . Oral Suspension . hears oral arguments . Oral Roberts . oral arguments . Oral Suspension Oral Suspension / formulations . Formulation . Formulations : proprietary formulation . gel formulation . dosage formulations . inhaled formulation . intravenous formulation . injectable formulation * *

Related by context. All words. (Click for frequent words.) 69 Laquinimod 69 tablet formulation 68 investigational oral 68 investigational compound 68 subcutaneous formulation 66 injectable formulation 66 intravenous formulation 66 tezampanel 66 oral prodrug 66 inhaled formulation 65 NGX# 65 NVA# 65 orally administered 65 investigational drug 65 subcutaneously administered 65 orally bioavailable 65 methylnaltrexone 64 immunomodulatory therapy 64 Phase 2a 64 Menerba 64 Phase 2b study 64 anticancer agent 63 ELND# 63 liposomal formulation 63 oral anticoagulant 63 Mipomersen 63 anticancer compound 63 administered subcutaneously 63 inhaled antibiotic 63 Phase 1b trial 63 RSD# 63 long acting muscarinic 63 generation purine nucleoside 63 tolerability profile 63 PDE4 inhibitor 62 tiapamil 62 Alvesco R 62 polymerase inhibitor 62 intranasal formulation 62 prodrug 62 octreotide acetate 62 Phase Ib study 62 HuMax CD4 62 pharmacokinetic profile 62 inhaled corticosteroid ICS 62 transdermal patch 62 BAY #-# 62 forodesine 62 Phase 2a trial 62 lomitapide 62 Phase 2a clinical 62 Phase Ib 62 administered orally 62 mTOR inhibitor 62 zileuton 62 ciprofloxacin hydrochloride 62 Phase IIa 62 AZILECT R 62 HCV protease inhibitor 62 Phase 2b trial 62 vidofludimus 62 HuMax CD# 62 nucleoside analog 62 Traficet EN 62 Relivar 61 Bezielle 61 alvimopan 61 cannabinor 61 ospemifene 61 oral bioavailability 61 Phase Ib clinical 61 Dapagliflozin 61 Zingo TM 61 JAK inhibitor 61 Plicera 61 CDP# 61 oxybutynin gel 61 DR Cysteamine 61 Phase IIa clinical 61 immunomodulator 61 investigational humanized monoclonal antibody 61 DDP# 61 diabetic neuropathic pain 61 inhaled formulations 61 rFIXFc 61 LIALDA 61 Civacir 61 incyclinide 61 selective modulator 61 Bicifadine 61 Prulifloxacin 61 PNP inhibitor 61 PTH1 61 Anidulafungin 61 Pazopanib 61 Phase IIa trial 61 adipiplon 61 peripherally acting 61 Phase 2b clinical 61 Tamibarotene 61 OMNARIS HFA 61 opioid analgesic 61 Phase III clinical 60 oral iron chelator 60 VAPRISOL 60 AGILECT R 60 Amphotericin B 60 mesalamine 60 multi kinase inhibitor 60 Panzem R NCD 60 granisetron 60 oral rivaroxaban 60 HFA MDI 60 trospium chloride 60 Certolizumab pegol 60 cangrelor 60 intravenously administered 60 LY# [003] 60 pharmacodynamic profile 60 omega interferon 60 topical formulation 60 Arikace 60 Fingolimod 60 agonist LABA 60 HGS# 60 Zelrix 60 oral dosing 60 oral antiviral 60 ganetespib 60 rhIGF-I/rhIGFBP-3 60 Lodotra TM 60 Extended Release Tablets 60 Interferon alpha 60 rFVIIIFc 60 acting muscarinic antagonist 60 Tezampanel 60 Pimavanserin 60 Tarceva TM 60 Elagolix 60 Zerenex 60 postoperative ileus 60 otelixizumab 60 Vaprisol 60 Maribavir 60 investigational 60 capsule formulation 60 AEG# 60 small molecule Hedgehog 60 visilizumab 60 transdermal spray 60 ulimorelin 60 oral salmon calcitonin 60 methylnaltrexone bromide 60 Pafuramidine 60 Milnacipran 60 Lodotra 60 HuMax EGFr 60 non nucleoside inhibitor 60 dalbavancin 60 Urocidin 60 trospium 60 prucalopride 60 histamine dihydrochloride 60 atypical antipsychotic 60 SARMs 60 Octreotide 60 Mitoxantrone 60 ATL# [001] 60 Archexin 60 bendamustine 60 GRALISE 60 nasal antihistamine 59 injectable antibiotic 59 LHRH antagonist 59 PRX # 59 Phase Ib clinical trials 59 biologic therapy 59 TELINTRA 59 AZILECT ® 59 injectable formulations 59 integrase inhibitor 59 CYC# 59 Phase 2b clinical trials 59 buccal tablet 59 Ceflatonin 59 Toctino ® alitretinoin 59 phase IIb clinical 59 CIP TRAMADOL ER 59 alvespimycin 59 novel prodrug 59 PSN# [002] 59 Indaflex TM 59 eniluracil 59 Cleviprex TM clevidipine 59 Icatibant 59 histone deacetylase HDAC inhibitor 59 MAGE A3 ASCI 59 EOquin 59 Cloretazine ® 59 MAP# 59 MEK inhibitors 59 Phase 1b clinical 59 Degarelix 59 registrational 59 Preclinical studies suggest 59 Dabigatran etexilate 59 EFAPROXYN 59 Guanilib 59 oral formulations 59 reslizumab 59 RECOTHROM R 59 amrubicin 59 Dalbavancin 59 Abiraterone acetate 59 torezolid phosphate 59 IMA# 59 DB# [003] 59 orally dosed 59 SNRI 59 pomalidomide 59 Mirapexin 59 Tyrima 59 investigational pan BCR 59 sorafenib tablets 59 pseudobulbar affect PBA 59 CR# vcMMAE 59 diarrhea predominant irritable 59 TBC# 59 Panzem R 59 SCH # 59 superficial bladder cancer 59 mesalazine 59 PHX# 59 LibiGel ® 59 subcutaneous SC 59 Perforomist TM Inhalation Solution 59 antiplatelet agent 59 phase Ib 59 indacaterol 59 dosing regimens 59 DORIBAX 59 CCR5 antagonist 59 sorafenib Nexavar 59 novel oral anticoagulant 59 Capesaris 59 INCB# [001] 59 ozarelix 59 EMBEDA ™ 59 Aurora kinase inhibitor 59 orally disintegrating tablets 59 monotherapy 59 Enhanze Technology 59 tasocitinib 59 Gabapentin GR 59 investigational antiplatelet agent 59 inhaled liposomal ciprofloxacin 59 Proquin XR 59 Phase IIb trials 59 CoFactor 59 tramiprosate 59 mertansine 59 cystinosis patients 59 Onsolis 59 Tolvaptan 59 tolerability 59 dosing regimen 59 inhaled iloprost 59 YONDELIS 59 USL# 59 adjunctive treatment 59 ONTAK 59 HDAC inhibitor 59 pharmacokinetic profiles 59 lucinactant 59 Sym# 59 Dyloject 59 Denufosol 59 PRTX 59 Silodosin 59 epothilone 59 Phase 1b 59 Rebif ® 59 CEQ# 59 nasal spray formulation 59 Clevudine 59 RG# [001] 59 metformin HCl 59 Tesetaxel 59 MEK inhibitor 59 Actemra tocilizumab 58 phase 2a 58 R#/MEM # 58 dopamine partial agonist 58 Bortezomib 58 inhibitor PPI 58 Fodosine 58 Marqibo 58 paclitaxel poliglumex 58 TAFA# 58 Clonicel 58 phase IIa clinical 58 sublingual formulation 58 RhuDex ® 58 Personalized Immunotherapy 58 PEGylated Fab fragment 58 Amrubicin 58 Onrigin 58 teduglutide 58 Keppra XR 58 laquinimod 58 octreotide implant 58 Anturol TM 58 pharmacodynamic properties 58 ADX# 58 ADP receptor antagonist 58 Zuplenz 58 oral transmucosal 58 OncoVEX GM CSF 58 TG# [003] 58 JAK2 inhibitor 58 Methylnaltrexone 58 BCR ABL inhibitor 58 LY# [002] 58 Aurexis 58 antimuscarinic agent 58 Nexavar ® 58 Orazol 58 MIRCERA 58 Hydroxyurea 58 orally administered inhibitor 58 faropenem medoxomil 58 AKT inhibitor 58 FTY# fingolimod 58 vorinostat 58 severe gastroparesis 58 Besivance 58 IPLEX 58 PEGylated 58 carfilzomib 58 Frova ® 58 humanized anti 58 KNS # 58 NMDA antagonist 58 mesylate 58 BAL# [002] 58 renin inhibitor 58 IAP inhibitors 58 tezampanel NGX# 58 amphotericin B 58 Ciclesonide 58 pegylated 58 Linjeta TM 58 TYZEKA 58 OSMOPREP 58 Phase Ia 58 cariprazine 58 faropenem 58 Topotecan 58 antisense drug 58 somatostatin analogue 58 LEP ETU 58 MBP# [001] 58 rHuPH# 58 Dual Opioid 58 receptor tyrosine kinase inhibitor 58 Altastaph 58 KRN# 58 Phase IIb trial 58 Aclidinium 58 Ofatumumab 58 EOquin TM 58 albiglutide 58 phase IIa 58 ABILIFY ® 58 INCB# [002] 58 Phase IIb clinical trials 58 Dasatinib 58 inhaled corticosteroid 58 Phase IIb clinical 58 diclofenac sodium 58 Myocet 58 veltuzumab 58 transcriptase inhibitor NNRTI 58 axitinib 58 Convivia TM 58 phase IIb 58 interferon beta 1b 58 OHR/AVR# 58 Lubiprostone 58 Japanese Encephalitis vaccine 58 Ophena TM 58 Teysuno 58 AeroLEF TM 58 antifungal agent 58 FOLOTYN ® 58 sublingual tablets 58 Azedra 58 APTIVUS 58 Xanafide 58 pivotal Phase III 58 Onbrez Breezhaler 58 developing Bicifadine serotonin 58 direct thrombin inhibitor 58 IAP inhibitor 58 angiogenesis inhibitor 58 Mycograb 58 Telavancin 58 Rasagiline 58 TEMODAL 58 ProSavin 58 Sanctura XR 58 Irinotecan 58 modulator SERM 58 OncoGel 58 Formoterol 58 Cimzia ® 58 Anthim 58 ZYBRESTAT 58 regorafenib 58 Pathway Inhibitor 58 Linaclotide 58 Zileuton 58 PI3K inhibitor 58 Lumacan 58 Azilect ® 58 xanthine oxidase inhibitor 58 Lixivaptan 58 inhalation powder 58 NKTR 58 fluoroquinolone antibiotic 58 teriflunomide 58 cilengitide 58 PD LID 58 Vernakalant 58 ONSOLIS 58 serotonin norepinephrine reuptake inhibitor 58 Fentanyl TAIFUN R 58 Crofelemer 58 antiarrhythmic agent 58 EZN 58 nasal formulation 58 Aviptadil 58 CorVue ™ 58 Phase #b/#a trial 58 ARIKACE 58 potent CYP#A# inhibitors 58 oxymorphone ER 58 Vilazodone 58 ruxolitinib 58 Serdaxin 58 NEBIDO 57 Clolar ® 57 selective antagonist 57 ANAVEX #-# [003] 57 Golimumab 57 Phase III trials 57 octreotide 57 Zavesca ® 57 XmAb# 57 Inhalation Solution 57 CA4P 57 Ganciclovir 57 proton pump inhibitor PPI 57 Oral Spray 57 belinostat 57 Cloretazine 57 Clofarabine 57 bromfenac 57 metastatic hormone refractory 57 INTELLITAB TM 57 pharmacokinetic properties 57 intravenous formulations 57 nucleoside analogs 57 Alpharadin 57 Sapacitabine 57 VA# [002] 57 Alinia 57 Prograf ® 57 gel formulation 57 MOVIPREP R 57 ritonavir boosted 57 antagonist LAMA 57 EVIZON 57 Hsp# inhibitor 57 vascular disrupting agent 57 ThermoDox ® 57 Safinamide 57 Lixisenatide 57 JANUVIA 57 PRT# 57 Tracleer R 57 ATL# [002] 57 humanized monoclonal antibody 57 orally disintegrating 57 Phase IIb 57 LCP AtorFen 57 apomorphine 57 Phenoptin 57 aerosol formulation 57 Aztreonam 57 RSD# oral 57 EndoTAG TM -1 57 luteinizing hormone releasing 57 recombinant human 57 herpetic keratitis 57 radiation sensitizer 57 Aflibercept 57 lapatinib Tykerb 57 evaluating tivozanib 57 Cethromycin 57 Darusentan 57 ocular formulation 57 Avanafil 57 PCK# 57 Voreloxin 57 daclizumab 57 GnRH antagonist 57 SinuNase 57 lubiprostone 57 nitazoxanide 57 atacicept 57 ALN TTR# 57 palonosetron 57 virus HCV protease inhibitor 57 efficacy tolerability 57 Nebido 57 orally inhaled 57 REVLIMID lenalidomide 57 HSP# inhibitor 57 GTC recombinant human 57 acyclovir Lauriad R 57 PROMACTA 57 zanolimumab 57 6R BH4 57 ZEGERID Capsules 57 rNAPc2 57 selective orally bioavailable 57 rasagiline tablets 57 Alzhemed TM 57 Rivaroxaban 57 immunosuppressant drug 57 Factor Xa inhibitor 57 ESBA# 57 sunitinib malate 57 relapsing remitting multiple sclerosis 57 ELADUR 57 synthetic retinoid 57 Zelapar 57 dirucotide 57 Hycamtin 57 topical formulations 57 Tavocept 57 aztreonam 57 Rituxan rituximab 57 Thiovir 57 Phase 1a clinical 57 ciclesonide 57 docetaxel Taxotere R 57 registrational trial 57 GLP1 agonist 57 systemically administered 57 erlotinib Tarceva ® 57 Pralatrexate 57 Junovan 57 proteasome inhibitor 57 MBP# dirucotide 57 guanfacine 57 Perifosine 57 enzyme inhibitor 57 SILENOR TM 57 anidulafungin 57 mGluR5 NAM 57 GALNS 57 5 HT3 antagonist 57 TYGACIL 57 Onconase 57 TOCOSOL Paclitaxel 57 entinostat 57 ELACYT 57 ZOMIG 57 Talabostat 57 injectable investigational 57 Raptiva ® 57 tanespimycin 57 elvucitabine 57 Daclizumab 57 betrixaban 57 oral Factor Xa 57 acting injectable formulation 57 febuxostat 57 selective kinase inhibitor 57 nucleotide analogue 57 docetaxel chemotherapy 57 ganaxolone 57 Retacrit 57 Tasimelteon 57 Factor VIIa 57 ketolide antibiotic 57 LCP Tacro 57 LATUDA 57 SUTENT ® 57 Valdoxan 57 Sanvar R 57 uric acid lowering 57 Pennsaid R 57 DexaSite 57 ATL/TV# 57 ADVANCE PD 57 entacapone 57 Locteron 57 corticosteroid dexamethasone 57 ibandronate 57 opioid agonist 57 Natalizumab 57 orally disintegrating tablet 57 elotuzumab 57 BRIM2 57 non nucleoside 57 Reverset 57 leading oral taxane 57 Moxifloxacin 57 obatoclax 57 PKC# 57 selective androgen receptor modulator 57 thetreatment 57 Oxaliplatin 57 ACUROX ® 57 olanzapine Zyprexa 57 BEMA TM Fentanyl 57 calcitonin 57 miconazole Lauriad ® 57 CD# antibody [001] 57 Targretin 57 Luteinizing Hormone Releasing Hormone 57 Everolimus 57 PXD# 57 quetiapine fumarate 57 SNT MC# 57 formoterol fumarate 57 Zalbin 57 INT# [002] 57 favorable pharmacokinetic profile 57 topical ophthalmic 57 TRANSDUR Sufentanil 57 Pirfenidone 57 aclidinium bromide 57 nebulized formoterol fumarate 57 linaclotide 57 GLPG# 57 ThGRF 57 mGluR2 positive 57 sitaxsentan 57 Vfend 57 cephalosporin antibiotic 57 clonidine hydrochloride 57 receptor antagonist 57 Dual Opioid TM 57 SCENESSE ® 56 AAG geldanamycin analog 56 tolerability profiles 56 LAF# 56 sodium stibogluconate 56 Oxytrex TM 56 SERMs 56 alfa interferon 56 opioid induced constipation 56 DepoDur 56 XIFAXAN R 56 microplasmin 56 vandetanib 56 transdermal gel 56 docetaxel Taxotere ® 56 Uricase PEG 56 bortezomib Velcade 56 NexACT ® 56 Emselex 56 edoxaban 56 ACTEMRA TM 56 atypical antipsychotic medication 56 Bendamustine 56 dose escalation clinical 56 LEVADEX ™ 56 anti emetic 56 proprietary transdermal patch 56 Rifaximin 56 Neo Urinary Conduit 56 randomized controlled Phase 56 MyVax R 56 carbidopa levodopa 56 ZOLINZA 56 glycopyrrolate 56 Perforomist ™ Inhalation Solution 56 Ixempra 56 alkylating agent 56 Tygacil 56 GLP toxicology studies 56 AEGR 56 TREDAPTIVE 56 anti androgen 56 Zoraxel 56 pitavastatin 56 EXALGO 56 DACH platinum 56 desvenlafaxine succinate 56 relapsed ovarian cancer 56 NeuroSTAT ® 56 Requip XL 56 CRMD# 56 SYCREST 56 immune modulatory 56 selective inhibitor 56 fluocinolone acetonide 56 ALVESCO HFA 56 receptor agonist 56 Serada 56 Bronchitol 56 Argatroban 56 Asentar 56 stated Michelle Berrey 56 ceftaroline 56 DPP4 inhibitor 56 DCCR 56 Phase IIa trials 56 Cimzia TM 56 Zavesca r 56 Nanobody 56 metaglidasen 56 PSN# [001] 56 Tocilizumab 56 Aztreonam lysine 56 pharmacokinetic studies 56 Cimzia R 56 CG# [003] 56 dyskinesia PD LID 56 noninfectious uveitis 56 alpha blocker 56 nucleotide analog 56 topical NSAID 56 rituximab Rituxan 56 ferric citrate 56 targeted radiotherapeutic 56 Ondansetron 56 subcutaneous RELISTOR 56 oral ridaforolimus 56 zafirlukast 56 long acting beta2 56 antiemetic 56 Ventavis 56 GV# [001] 56 ATD gel 56 Dyloject TM 56 clofarabine 56 tiotropium bromide 56 Onalta 56 interferon beta 1a 56 Zebinix R 56 fostamatinib 56 Afresa 56 VEGF Trap 56 active comparator 56 Sitagliptin 56 Zenvia ™ 56 INVEGA ® 56 nucleoside analogue 56 anti emetic therapy 56 ADL# novel 56 Seliciclib 56 antidepressant trazodone 56 postoperative ileus POI 56 MAXY G# 56 dexpramipexole 56 Mycamine 56 IMC A# 56 AVE# 56 Phase #/#a 56 SEROQUEL 56 Palonosetron 56 Vidofludimus 56 TNF Tumor Necrosis Factor 56 adjunctive therapy 56 hGH CTP 56 ThermoDox R 56 cetrorelix 56 Afatinib 56 ocular hypertension 56 calcineurin inhibitor 56 DU #b 56 Phase IIIb clinical 56 mu opioid receptor antagonist 56 opioid induced bowel dysfunction 56 relapsed multiple myeloma 56 paliperidone palmitate 56 Relistor 56 Prosaptide 56 relapsing multiple sclerosis 56 TRO# 56 BYETTA ® 56 ELIQUIS 56 nab paclitaxel 56 Lacosamide 56 intravenous dosing 56 MNTX 56 cyclobenzaprine hydrochloride extended 56 liprotamase 56 novel histone deacetylase 56 anti angiogenic agent 56 Hyphanox 56 Firazyr 56 sulodexide 56 XYZAL R 56 calcipotriene 56 MDV# 56 CD# monoclonal antibody 56 pregabalin Lyrica 56 Cloretazine R VNP#M 56 Azacitidine 56 alpha interferon 56 Elvitegravir 56 dihydrochloride 56 pertuzumab 56 Synavive 56 tenofovir Viread 56 miglustat 56 Ropinirole 56 interferon gamma 1b 56 Tanespimycin 56 PEG SN# 56 Octreolin 56 PRISTIQ 56 Lamictal ODT 56 timolol 56 Intuniv 56 estrogen receptor antagonist 56 APTIVUS r 56 EvaMist TM 56 Debio 56 QD dosing 56 albinterferon alfa 2b 56 proteasome inhibitors 56 multiple ascending dose 56 Tofacitinib 56 diabetic macular edema DME 56 Revlimid lenalidomide 56 confirmatory Phase III 56 Tasigna nilotinib 56 boosted protease inhibitor 56 TH# [003] 56 opioid antagonist 56 LEVADEX 56 sapropterin dihydrochloride 56 Xibrom QD 56 bronchodilation 56 bicifadine 56 selective adenosine 56 DepoDur TM 56 treprostinil 56 Microplasmin 56 Ziprasidone 56 dose escalation trial 56 VNP#M 56 induced macular edema 56 FACTIVE R gemifloxacin 56 Aerosurf 56 levetiracetam 56 IMiDs R 56 anti TNF alpha 56 Nasal Spray 56 hepatitis C protease inhibitor 56 pharmacokinetic PK study 56 paclitaxel Taxol 56 CRD5 56 Ventavis ® 56 goserelin 56 fluticasone furoate 56 Levoleucovorin 56 Pagoclone 56 pivotal Phase 56 Zerenex ™ 56 refractory gout 56 Reolysin 56 IMiDs ® 56 OZURDEX ® 56 oral taxane 56 Chemophase 56 basal insulin 56 Zavesca R 56 PEG Interferon lambda 56 HCV protease inhibitors 56 Lofexidine 56 beta 1a 56 chemotherapeutic agent 56 LIVALO 56 riociguat 56 ISIS # 56 Genz # 56 administered intranasally 56 Phase III 56 Xeloda ® 56 perifosine 56 Hsp# Inhibitor 56 LEVADEX TM 56 enteric coated 56 Pradefovir 56 ondansetron 56 Technosphere Insulin 56 oritavancin 56 Initiate Phase 56 Copegus ribavirin 56 vapreotide acetate 56 Phase Ib II 56 ALVESCO R 56 eltrombopag 56 basal insulin analogue 56 lurasidone 56 trabectedin 56 GAMMAGARD 56 Belerofon 56 adalimumab Humira 56 oxaliplatin Eloxatin 56 oral RSD# 56 CIMZIA TM 56 MGCD# [001] 56 2 methoxyestradiol 56 Zolpimist 56 TREANDA 56 dermal patch 56 Meets Primary Endpoint 56 APEX PD 56 Noxafil 56 refractory CLL 56 talactoferrin 56 CCR9 antagonist 56 Stavzor 56 TYKERB 56 Application MAA 56 HQK 56 PF # [001] 56 ADAGIO study 56 sNDA 56 ORENCIA R 56 EpiCeram 56 Kuvan R 56 parenterally administered 56 GlycoPEG GCSF 56 DAVANAT R 56 Phase III clinical trials 56 oropharyngeal candidiasis 56 Gel repository corticotropin injection 56 Velcade bortezomib 56 phase Ib clinical 56 APD# 56 BCR ABL inhibitors 56 itraconazole 56 pramlintide 56 AGILECT ® 56 anti EGFR antibody 56 TNF alpha inhibitor 56 Serdolect ® 56 MAA submission 56 painful diabetic neuropathy 55 thrombolytic agent 55 prGCD 55 PEG PAL 55 Amigal 55 partial agonist 55 Darunavir 55 RH1 55 ALGRX 55 YONDELIS R 55 Oxytrex 55 Valtropin 55 Diabetic Macular Edema 55 TACI Ig 55 EFFEXOR XR 55 Rotigotine 55 echinocandin 55 ISENTRESS raltegravir 55 double blinded placebo 55 CINTREDEKIN BESUDOTOX 55 CLORETAZINE TM VNP#M 55 small molecule thrombopoietin 55 REPLAGAL 55 rilonacept 55 Advagraf 55 Inhalation Aerosol 55 Zysolin TM 55 KAPVAY ™ 55 dronabinol 55 VALSTAR 55 pegylated interferon alfa 2a 55 RLY# 55 Microcyn Technology 55 PROVENGE sipuleucel T 55 synthetic progestin 55 CYT# QbG# 55 placebo controlled clinical 55 APRISO 55 trabedersen 55 dosage regimen

Back to home page